In prognostic, diagnostic, and risk-prediction models, a meta-analysis of 40 studies (17,246 patients) found deep learning and radiomics detect extracranial carotid plaques with pooled sensitivity 0.88 and specificity 0.89, while a separate meta-analysis of axillary lymph node metastasis detection in breast cancer reported sensitivity/specificity of 0.79/0.86 for ultrasound-based models and 0.78/0.82 for MRI-based models. In a cohort of 11,361 tuberculosis patients, random forest and XGBoost reached validation AUCs of 0.960 and 0.954 for predicting antituberculosis drug-induced liver injury, with population-stratified models outperforming a single universal one. Elsewhere, a CT-CLIP foundation model improved lung cancer prognosis prediction over a clinical-variable-only baseline, and a GRU-based model generated time-updated risk scores for metastatic prostate cancer from routine visit data alone.

In large language models in healthcare, PrIME-LLM, tested across 21 LLMs including GPT-5 and Grok 4 on 29 standardized clinical vignettes, found models reached correct final diagnoses over 90% of the time with full case information but performed far worse at the earlier, open-ended stages of a case. GPT-5 reached 82.1% accuracy on TNM cancer staging from 552 PET-CT reports, edging out junior radiologists (77.0%). A randomized controlled trial found AI-generated previsit document summaries shortened neurosurgical consultations from a median of 33 to 25 minutes and left patients feeling more informed, though physicians rated their own autonomy somewhat lower.

In agentic AI for health research, a hierarchical multi-agent system trained with process-level rewards raised gene-disease validity curation accuracy to 0.750 and process-fidelity F1 to 0.520, both above outcome-only reward training. EmulatRx, a five-agent LLM framework for clinical trial design using real-world data, reproduced many previously reported treatment effects across historical trials spanning heart failure, septic shock, and other conditions. A separate study found an orchestrated multi-agent architecture held accuracy far better than a single agent as clinical workload scaled up (90.6% to 65.3% versus 73.1% to 16.6% accuracy), while cutting token usage up to 65-fold.

Across today's studies, stratifying by subgroup, supervising intermediate reasoning steps, and testing under realistic workload or case-complexity conditions prove more informative than single aggregate accuracy figures.

Sources

  1. Diagnostic performance of deep learning and radiomics in extracranial carotid plaque detection
  2. Accuracy of deep learning for detecting axillary lymph node metastasis in breast cancer
  3. Stratified machine learning models for predicting antituberculosis drug-induced liver injury
  4. Large Language Model Performance and Clinical Reasoning Tasks (PrIME-LLM)
  5. Evaluating LLMs for automated TNM staging from PET-CT reports
  6. Effect of previsit AI-generated document summaries on consultation time and communication (AI-INFOCARE RCT)
  7. Process-supervised multi-agent reinforcement learning for reliable clinical reasoning
  8. Empowering clinical trial design with agentic intelligence and real-world data (EmulatRx)
  9. Orchestrated multi-agents sustain accuracy under clinical-scale workloads

Prepared with AI assistance from newly published research. See the sources for the original studies.

Share Facebook WhatsApp
End of articleBack to all writing →
Dr. Md Abdullah Saeed Khan

Physician, epidemiologist and researcher. DPhil fellow in Clinical Medicine at the University of Oxford.